Table 1. Midterm progress in the health sector’s national strategic plan for 2009–2015, United Republic of Tanzania.
Health indicator | Data source | Baseline |
Achievement |
Target valuea | Inequity | |||
---|---|---|---|---|---|---|---|---|
Year | Value | Year | Value | |||||
Life expectancy for males/females, years | PS/C | 2002 | 51/52 | 2011 | 58/61 | 59/62 | ND | |
Child mortality rate, deaths per 1000 live births | PS/C | 2004–2008 | 91 | 2006–2010 | 81 | 54 | ND | |
Neonatal mortality rate, deaths per 1000 live births | PS/C | 2004–2008 | 29 | 2006–2011 | 26 | 19 | ND | |
Infant mortality rate, deaths per 1000 live births | PS/C | 2004–2008 | 58 | 2006–2012 | 51 | NS | ND | |
Stunting among children younger than five years, % | PS/C | 2004–2005 | 38 | 2010 | 35 | 27 | S, R and W | |
Underweight among children younger than five years, % | PS/C | 2004–2005 | 22 | 2010 | 14 | 14 | ND | |
Maternal mortality ratio, deaths per 100 000 live births | PS/C | 1996–2005 | 578 | 2004–2010 | 454 | 156 | ND | |
Total fertility rate, live births per woman | PS/C | 2003–2005 | 5.7 | 2008–2010 | 5.4 | 5.1 | R and W | |
Adolescent fertility rate, % of women who either had a live birth or were pregnant with first child, before 20 years of age | PS/C | 2003–2005 | 52 | 2010 | 44 | 39 | R and W | |
HIV prevalence, % | ||||||||
Females/males aged 15–24 years | PS/C | 2008 | 3/1.1 | 2011–2012 | 2.8/1.2 | NS | S | |
Pregnant women | HFD | 2005–2006 | 6.8 | NA | NA | NS | ND | |
People aged15–49 years | PS/C | 2007–2008 | 5.8 | 2011–2012 | 5.3 | NS | ND | |
Tuberculosis notification rate, cases per 100 000 population | HFD | 2008 | 159 | 2011 | 142 | NS | S | |
Cholera incidence | HFD | 2008 | 2391 | 2011 | 343 | 0 | ND | |
Cholera case fatality, % | HFD | 2008 | 3 | 2011 | 4 (98/2391) | < 1 | ND | |
Malaria prevalence among outpatients younger than five years, % | HFD | 2009 | 40 | 2012 | 33 | NS | ND | |
Prevalence of malarial parasitaemia among children younger than five years, % | PS/C | 2008 | 18 | 2012 | 9.2 | 5 | ND | |
Coverage, % of target group | ||||||||
Measles immunization (0–11 months) | HFD | 2008 | 91 | 2012 | 100 | 85 | ND | |
Third dose of diphtheria–tetanus–pertussis–Hib (0–11 months) | HFD | 2008 | 92 | 2012 | 95 | 85 | ND | |
Two-dose vitamin A (6–59 months) | PS/C | 2004–2005 | 46 | 2010 | 60 | 90 | S and W | |
Second dose of tetanus toxoid during pregnancy | PS/C | 2000–2005 | 5 | 2011 | 88 | 90 | ND | |
First antenatal care visit at more than 16 weeks’ gestation, % of pregnant women | PS/C | 2000–2005 | 14 | 2006–2010 | 15 | 60 | R | |
At least four antenatal care visits, % of pregnant women | PS/C | 2000–2005 | 64 | 2009–2010 | 36 | 90 | R | |
Births in health facilities, % | HFD | 2007 | 51 | 2011 | 58 | 70 | R and W | |
Skilled birth attendance, % of births | PS/C | 2000–2005 | 46 | 2010–2011 | 56 | 80 | R and W | |
Contraceptive use, % of married women | PS/C | 2004–2005 | 20 | 2010 | 27 | 60 | R and W | |
Use of insecticide-treated bednets by children/pregnant women, % | PS/C | 2008 | 26/27 | 2011–2012 | 73/75 | 80 | ND | |
Two-dose intermittent preventive treatment against malaria, % of pregnant women | PS/C | 2008 | 30 | 2011–2012 | 31 | 80 | ND | |
Prophylaxis for mother-to-child transmission of HIV, % coverage among pregnant women | HFD | NA | NA | 2011 | 71 | 80 | ND | |
Antiretroviral coverage, % | HFD | NA | NA | 2012 | 65 | 60 | ND | |
Tuberculosis treatment success rate, % | HFD | 2008 | 89 | 2011 | 88 | 85 | ND | |
Government expenditure on health, % of total expenditure | AD | 2008–2009 | 12 | 2012 | 10 | 15 | ND | |
Total health expenditure per capita, US$ | AD | 2008 | 26 | 2011 | 37 | NS | ND | |
Insurance coverage, % | AD | 2007 | 9 | 2012 | 14 | 80 | ND | |
Health workforce, no. per 10 000 population | ||||||||
Doctors and assistant medical officers | AD | 2004–2005 | 0.7 | 2012 | 0.9 | NS | ND | |
Nurses and midwives | AD | 2004–2005 | 2.6 | 2012 | 4.9 | NS | ND | |
Pharmacists | AD | 2004–2005 | 0.15 | 2012 | 0.12 | NS | ND | |
Outpatient visits per person-year | AD | 2012 | 0.78 | 2012 | 0.69 | NS | ND | |
Training institutes with full accreditation | AD | 2008 | 1 | 2012 | 56 | 30 | ND | |
Basic emergency obstetric care, % of facilities | HFD | NA | NA | 2012 | 20 | 70 | ND | |
Districts with timely surveillance reports, % | AD | 2008 | 60 | 2012 | 73 | > 90 | ND | |
No. of stockouts of tracer medicines and vaccines | HFD | 2006 | 0 | 2013 | 19 | NS | ND |
AD: administrative data; HFD: health facility data; Hib: Haemophilus influenzae type b; HIV: human immunodeficiency virus; NA: not available; ND: none detected; NS: none set; PS/C: population survey or census; R: region of residence; S: sex; US$: United States Dollars; W: wealth quintile.
a To be achieved by the end of 2015.